Table 2.
Some pathways under investigation for new HF drugs.
Apelin |
Interleukin-1b receptor antagonists |
Atrial natriuretic peptides |
Mineralocorticoid receptor antagonists |
β3 agonists |
Mitochondrial targeting peptide |
Neuregulin-1 |
Cardiac ion channels modulator |